Long-term management of immunosuppression after pediatric liver transplantation: is minimization or withdrawal desirable or possible or both?
about
Posttransplant metabolic syndrome in the withdrawal of immunosuppression in Pediatric Liver Transplant Recipients (WISP-R) pilot trialCD39 deficiency in murine liver allografts promotes inflammatory injury and immune-mediated rejection.The liver works as a school to educate regulatory immune cells.CD4(+)Foxp3(+) regulatory T cell therapy in transplantation.Immunomodulating options for liver transplant patients.Pediatric transplantation and tolerance: past, present, and future.Clinical transplantation and tolerance: are we there yet?Regulatory T cells: tolerance induction in solid organ transplantation.Decreased risk of graft failure with maternal liver transplantation in patients with biliary atresia.Markers of operational immune tolerance after pediatric liver transplantation in patients under immunosuppression.Cell Therapy in Organ Transplantation: Our Experience on the Clinical Translation of Regulatory T Cells.
P2860
Q28647771-1263F7B9-39E0-4107-A43C-E17BB3DD88D9Q35202450-782D1068-9EC4-46BB-A339-FC8AA0F671DDQ37729659-C419132C-D60D-4A42-8E7E-D8D688CBFA3EQ37968576-E95DE165-E9C7-4B67-9F2E-B955EC33048AQ38044761-03E08789-9B79-46DB-9B77-A4C3B6EFE196Q38220417-0907A851-AC85-47C7-ABE8-B244E4F43E40Q38271605-E1163ABD-2811-433E-B78C-E5279FCAC311Q38557841-CA1E598E-F93F-430D-92B0-2F7B82364B56Q46081051-357B86E2-397A-412E-9FB3-D41C7DE4474EQ50974523-84899621-0E7C-4ACB-8C4B-7F5BE8FDAA41Q52657146-2A833D45-813B-4AB4-A39F-A4DA480AD8E1
P2860
Long-term management of immunosuppression after pediatric liver transplantation: is minimization or withdrawal desirable or possible or both?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Long-term management of immuno ...... desirable or possible or both?
@en
Long-term management of immuno ...... desirable or possible or both?
@nl
type
label
Long-term management of immuno ...... desirable or possible or both?
@en
Long-term management of immuno ...... desirable or possible or both?
@nl
prefLabel
Long-term management of immuno ...... desirable or possible or both?
@en
Long-term management of immuno ...... desirable or possible or both?
@nl
P2860
P1476
Long-term management of immuno ...... desirable or possible or both?
@en
P2093
Sandy Feng
P2860
P304
P356
10.1097/MOT.0B013E328310B0F7
P577
2008-10-01T00:00:00Z